Agarose Injections
Ingredient: Agarose
Specification: 1 ml
Package: Single package
Application Area: Fine lines and wrinkles on the face, lip contours, and mid-depth facial remodeling.
Product Introduction:
It can smooths fine lines around the eyes, reduces tear trough hollowness, and enhances lip volume and improves marionette lines, refines wrinkles, and defines the lip contour. Corrects moderate to severe wrinkles, reshapes the nasolabial folds, chin, jawline, cheekbones, and nose, also provides deep structural support, contouring the chin, cheeks, cheekbones, nose, and restoring lost volume.
Product Display:
Product Details:
Type | |
Ingredient | Agarose |
Specification | AH1(10mg/mL) |
Effect area | Superficial to intermediate dermis |
Application area | AH1: Small wrinkles around the eyes, tears, fullness of the lips |
How to choose | Moderate to severe naso-lip wrinkles |
Package | Single package |
Storage | Room temperature |
Recommended | 1-2 pc/time |
Recommended interval | 12 months |
Lasting time | 12-36 months |
Collagen content | 10mg/mL,15mg/mL,25mg/mL,35mg/mL |
Product Package:
Customer Feedback:
Raw Material Advantages:
Derived from Natural Ingredients, Biocompatible:
Sourced from marine seaweed
Chemically stable and electrically neutral
Possesses suitable mechanical strength and degradability
Mimics the extracellular matrix with a three-dimensional, easily moldable structure
Crosslinker-Free Formula:
Self-gelling properties eliminate the need for additional crosslinkers
No chemical crosslinker residues
High safety for repeated use and injections
Development Process:
Company Introduction:
Our expertise in medical-grade material modification stems from 15 years of experience in polysaccharide crosslinking, enabling the refinement of chitosan into carboxymethyl chitosan (applied in an anti-adhesion surgical solution) and sodium hyaluronate into crosslinked sodium hyaluronate using sophisticated biphasic, monophasic, and micro-crosslinking methods. We also specialize in microsphere preparation, offering crosslinked starch microspheres (approved as microporous polysaccharide hemostatic powder), solvent-free injectable PCL, emulsification-based injectable PLLA, and injectable PMMA microspheres.